Firefly Neuroscience, Inc. (AIFF) - Net Assets

Latest as of September 2025: $9.66 Million USD

Based on the latest financial reports, Firefly Neuroscience, Inc. (AIFF) has net assets worth $9.66 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($12.41 Million) and total liabilities ($2.75 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore balance sheet size of Firefly Neuroscience, Inc. for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric Value
Current Net Assets $9.66 Million
% of Total Assets 77.84%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility 78.61

Firefly Neuroscience, Inc. - Net Assets Trend (2020–2024)

This chart illustrates how Firefly Neuroscience, Inc.'s net assets have evolved over time, based on quarterly financial data. Check AIFF goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Firefly Neuroscience, Inc. (2020–2024)

The table below shows the annual net assets of Firefly Neuroscience, Inc. from 2020 to 2024. For live valuation and market cap data, see AIFF market cap.

Year Net Assets Change
2024-12-31 $-375.00K -444.04%
2023-12-31 $109.00K +105.16%
2022-12-31 $-2.11 Million +29.96%
2021-12-31 $-3.01 Million -286.81%
2020-12-31 $1.61 Million --

Equity Component Analysis

This analysis shows how different components contribute to Firefly Neuroscience, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 7477848600.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components $86.71 Million %
Total Equity $-375.00K 100.00%

Firefly Neuroscience, Inc. Competitors by Market Cap

The table below lists competitors of Firefly Neuroscience, Inc. ranked by their market capitalization.

Company Market Cap
Rubberex Corporation M Bhd
KLSE:7803
$15.22 Million
Prairie Provident Resources Inc
TO:PPR
$15.22 Million
Dynaciate Group Bhd
KLSE:5178
$15.23 Million
Loyal Lithium Ltd.
AU:LLI
$15.23 Million
Domo Activos Socimi SA
MC:DOMO
$15.21 Million
Condor Resources Inc
V:CN
$15.21 Million
NexturnBioscience Co. Ltd
KQ:089140
$15.20 Million
BEYOND MED TEC. INC. NEW
F:7FM
$15.19 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Firefly Neuroscience, Inc.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 109,000 to -375,000, a change of -484,000 (-444.0%).
  • Net loss of 10,460,000 reduced equity.
  • New share issuances of 4,308,000 increased equity.
  • Other factors increased equity by 5,668,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-10.46 Million -2789.33%
Share Issuances $4.31 Million +1148.8%
Other Changes $5.67 Million +1511.47%
Total Change $- -444.04%

Book Value vs Market Value Analysis

This analysis compares Firefly Neuroscience, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2020-12-31 $0.20 $1.07 x
2021-12-31 $-0.38 $1.07 x
2022-12-31 $-0.27 $1.07 x
2023-12-31 $0.01 $1.07 x
2024-12-31 $-0.06 $1.07 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Firefly Neuroscience, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -9685.19%
  • • Asset Turnover: 0.02x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-472.49%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2020 25.62% 2.97% 3.68x 2.34x $252.04K
2021 0.00% -13690.63% 0.03x 0.00x $-4.08 Million
2022 0.00% 0.00% 0.00x 0.00x $-3.58 Million
2023 -2388.07% -522.69% 0.19x 24.23x $-2.61 Million
2024 0.00% -9685.19% 0.02x 0.00x $-10.42 Million

Industry Comparison

This section compares Firefly Neuroscience, Inc.'s net assets metrics with peer companies in the Software - Application industry.

Industry Context

  • Industry: Software - Application
  • Average net assets among peers: $1,110,453,128
  • Average return on equity (ROE) among peers: -6.76%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Firefly Neuroscience, Inc. (AIFF) $9.66 Million 25.62% 0.28x $15.21 Million
Adobe Systems Incorporated (ADBE) $23.50 Million 38.30% 0.37x $87.82 Billion
ADEIA CORP (ADEA) $545.10 Million -11.47% 0.92x $2.94 Billion
Automatic Data Processing Inc (ADP) $3.98 Billion 43.59% 8.35x $90.25 Billion
Autodesk Inc (ADSK) $243.60 Million 17.08% 1.02x $48.93 Billion
AudioEye Inc (AEYE) $5.86 Million -166.28% 0.21x $71.03 Million
Agilysys Inc (AGYS) $102.70 Million 19.18% 1.14x $2.96 Billion
BlockchAIn Digital Infrastructure, Inc (AIB) $10.70 Million 0.00% 0.35x $43.69 Million
XIAO-I Corporation American Depositary Shares (AIXI) $-3.38 Million 0.00% 0.00x $8.14 Million
Alight Inc (ALIT) $5.09 Billion -1.22% 1.21x $714.34 Million

About Firefly Neuroscience, Inc.

NASDAQ:AIFF USA Software - Application
Market Cap
$15.21 Million
Market Cap Rank
#25903 Global
#5364 in USA
Share Price
$1.07
Change (1 day)
+5.94%
52-Week Range
$0.64 - $3.05
All Time High
$175.50
About

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depres… Read more